Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dihydrofolate reductase (DHFR) is an essential enzyme found in bacteria that catalyzes the reduction of 7,8-dihydrofolate (DHF) to 5,6,7,8-tetrahydrofolate (THF), using NADPH. It is crucial for maintaining cellular pools of THF, which are required for the synthesis of purines and thymidylate for DNA and RNA synthesis. Inhibition of bacterial DHFR is a validated antibacterial strategy.
Inhibition of bacterial dihydrofolate reductase, leading to depletion of tetrahydrofolates and cessation of DNA synthesis.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dihydrofolate Reductase (Bacterial) (DHFR).